IN8bio, Inc.

General ticker "INAB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $23.0M (TTM average)

IN8bio, Inc. does not follow the US Stock Market performance with the rate: -26.4%.

Estimated limits based on current volatility of 4.4%: low 0.17$, high 0.19$

Factors to consider:

  • Earnings expected soon, date: 2025-05-08 bmo

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.18$, 0.81$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.28$, 1.06$]

Financial Metrics affecting the INAB estimates:

  • Negative: Non-GAAP EPS, $ of -0.58 <= 0.04
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -60.82 <= 1.79
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Negative: negative Operating income
  • Positive: Investing cash flow per share, $ of 0 > -0.09
  • Negative: negative Industry operating income (median)
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term INAB quotes

2025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-290.140.160.180.20.220.24
Price $

Long-term INAB plot with estimates

00.511.522.53Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.2−0.15−0.1−0.050
INABS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $28.52MM $30.34MM $30.44MM
Operating Income $-28.52MM $-30.34MM $-30.44MM
Non-Operating Income $0.00MM $0.33MM $0.00MM
R&D Expense $14.06MM $16.83MM $16.96MM
Income(Loss) $-28.52MM $-30.01MM $-30.44MM
Profit(Loss)* $-27.42MM $-30.01MM $-30.44MM
Stockholders Equity $22.73MM $24.94MM $14.48MM
Assets $33.04MM $33.71MM $20.94MM
Operating Cash Flow $-24.12MM $-23.34MM $-24.15MM
Capital expenditure $3.71MM $0.60MM $0.10MM
Investing Cash Flow $-3.71MM $-0.60MM $-0.19MM
Financing Cash Flow $8.99MM $27.04MM $14.18MM
Earnings Per Share** $-1.31 $-1.00 $-0.57

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.